UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.497

Sortiert nach

Progress in the research of gene mutations in follicular lymphoma

Zhōnghuá xuèyèxué zázhì, 2020-02, Vol.41 (2), p.172-176

2020

Link zum Volltext

Verfügbarkeit prüfen

The clinical trials of China innovative new anti-cancer drugs

Zhōnghuá zhŏngliú zázhì, 2019-01, Vol.41 (1), p.68

2019

Link zum Volltext

Verfügbarkeit prüfen

The Relationship Between Systemic Lupus Erythematosus and Osteoporosis Based on Different Ethnic Groups: a Two-Sample Mendelian Randomization Analysis

Calcified tissue international, 2024-04, Vol.114 (4), p.386-396

2024

Link zum Volltext

Verfügbarkeit prüfen

Research progress of prognostic biomarkers in diffuse large B-cell lymphoma

Zhōnghuá zhŏngliú zázhì, 2020-12, Vol.42 (12), p.989

2020

Link zum Volltext

Verfügbarkeit prüfen

Hydraulic Fracture Propagation in Rock Mass with XFEM

Soil mechanics and foundation engineering, 2023-11, Vol.60 (5), p.436-443

2023

Link zum Volltext

Verfügbarkeit prüfen

Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors

Zhōnghuá zhŏngliú zázhì, 2018-07, Vol.40 (7), p.490

2018

Link zum Volltext

Verfügbarkeit prüfen

The development of biosimilars in oncology

Zhōnghuá zhŏngliú zázhì, 2017-10, Vol.39 (10), p.721

2017

Link zum Volltext

Verfügbarkeit prüfen

Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model

Zhōnghuá zhŏngliú zázhì, 2022-02, Vol.44 (2), p.167

2022

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune disease development before and after cutaneous lupus erythematosus diagnosis

British journal of dermatology (1951), 2020-05, Vol.182 (5), p.1309-1310

2020

Link zum Volltext

Verfügbarkeit prüfen

Plinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

Annals of oncology, 2018-10, Vol.29, p.viii604-viii604

2018

Link zum Volltext

Verfügbarkeit prüfen

Progress in research of predictive markers and drug resistance mechanisms of immune checkpoint inhibitor

Zhong hua yi xue za zhi, 2018-12, Vol.98 (48), p.3917-3920

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma

Zhōnghuá zhŏngliú zázhì, 2020-03, Vol.42 (3), p.234

2020

Link zum Volltext

Verfügbarkeit prüfen

AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)

Annals of oncology, 2018-11, Vol.29, p.ix157-ix157

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical research and drug review of epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2019-12, Vol.41 (12), p.949

2019

Link zum Volltext

Verfügbarkeit prüfen

Surgical treatment of port-site metastases after laparoscopic radical resection of gastric cancer

Zhong hua yi xue za zhi, 2019-08, Vol.99 (32), p.2497-2500

2019

Link zum Volltext

Verfügbarkeit prüfen

Programmed cell death-1 inhibitor combined with rituximab in refractory or relapsed diffuse large B-cell lymphoma: a preliminary efficacy and safety analysis

Zhōnghuá zhŏngliú zázhì, 2020-12, Vol.42 (12), p.1034

2020

Link zum Volltext

Verfügbarkeit prüfen

Peripheral T cell lymphoma treatment in the precision medicine era

Zhong hua yi xue za zhi, 2016-11, Vol.96 (42), p.3361-3364

2016

Link zum Volltext

Verfügbarkeit prüfen

ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test

Annals of oncology, 2018-11, Vol.29, p.ix143-ix143

2018

Link zum Volltext

Verfügbarkeit prüfen

Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma

Zhōnghuá zhŏngliú zázhì, 2018-06, Vol.40 (6), p.456

2018

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and influence factors analysis of EGFR TKIs on patients with lung adenosquamous carcinoma

Zhōnghuá zhŏngliú zázhì, 2018-10, Vol.40 (10), p.776

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii503-viii504

2018

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

Leukemia, 2008-01, Vol.22 (1), p.179-185

2008

Link zum Volltext

Verfügbarkeit prüfen

Relationship of C1QA level and therapeutic effect and prognosis of DLBCL patients treated with R-CHOP

Zhōnghuá zhŏngliú zázhì, 2021-12, Vol.43 (12), p.1310

2021

Link zum Volltext

Verfügbarkeit prüfen

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Annals of oncology, 2017-10, Vol.28 (10), p.2443

2017

Link zum Volltext

Verfügbarkeit prüfen

Considerations for anti-cancer drug application by single arm trials

Zhōnghuá zhŏngliú zázhì, 2018-01, Vol.40 (1), p.58

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.497

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.238)
Mit Volltextzugriff
(1.400)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(852)
Physical Sciences
(437)
Physics
(404)
Technology
(285)
Life Sciences & Biomedicine
(270)
Humans
(202)
Materials Science
(151)
Chemistry
(135)
Male
(121)
Exact Sciences And Technology
(118)
Materials Science, Multidisciplinary
(115)
Engineering
(113)
Animals
(106)
Female
(104)
Physics, Applied
(101)
Biological And Medical Sciences
(96)
Astronomy & Astrophysics
(83)
Physics, Particles & Fields
(79)
Middle Aged
(73)
Chemistry, Physical
(70)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Progress in the research of gene mutations in follicular lymphoma

The clinical trials of China innovative new anti-cancer drugs

The Relationship Between Systemic Lupus Erythematosus and Osteoporosis Based on Different Ethnic Groups: a Two-Sample Mendelian Randomization Analysis

Research progress of prognostic biomarkers in diffuse large B-cell lymphoma

Hydraulic Fracture Propagation in Rock Mass with XFEM

Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors

The development of biosimilars in oncology

Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model

Autoimmune disease development before and after cutaneous lupus erythematosus diagnosis

Plinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

Progress in research of predictive markers and drug resistance mechanisms of immune checkpoint inhibitor

Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma

AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)

Clinical research and drug review of epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer

Surgical treatment of port-site metastases after laparoscopic radical resection of gastric cancer

Programmed cell death-1 inhibitor combined with rituximab in refractory or relapsed diffuse large B-cell lymphoma: a preliminary efficacy and safety analysis

Peripheral T cell lymphoma treatment in the precision medicine era

ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test

Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma

The efficacy and influence factors analysis of EGFR TKIs on patients with lung adenosquamous carcinoma

Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

Relationship of C1QA level and therapeutic effect and prognosis of DLBCL patients treated with R-CHOP

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Considerations for anti-cancer drug application by single arm trials

Suchergebnisse filtern